Detalles de la búsqueda
1.
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia.
Scand J Gastroenterol
; 58(1): 25-33, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35996928
2.
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol
; 18(10): 2295-2304.e2, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068151
3.
Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
Hepatology
; 77(6): E188-E189, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815351
4.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Lancet
; 389(10086): 2304-2316, 2017 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28502609
5.
Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
Scand J Gastroenterol
; 53(3): 297-304, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301479
6.
No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol
; 14(12): 1806-1812, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27521513
7.
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency.
Am J Gastroenterol
; 111(10): 1467-1475, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27527747
8.
Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply.
Lancet
; 390(10111): 2436, 2017 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29208304
9.
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Nat Commun
; 14(1): 3304, 2023 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37280200
10.
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.
Arthritis Rheumatol
; 74(8): 1321-1332, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507355
11.
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study.
Lancet Rheumatol
; 4(3): e177-e187, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34977602
12.
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
Trials
; 21(1): 13, 2020 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907007
13.
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
BioDrugs
; 34(5): 681-694, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32965617
14.
Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease.
J Crohns Colitis
; 4(5): 561-6, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21122560
Resultados
1 -
14
de 14
1
Próxima >
>>